IRMD vs K · P/E 51, rev $73.2M vs P/E 23, $29.03B cap
Iradimed Co (IRMD) versus Kellanova (K) — a side-by-side from cached financials, not a winner call.
Iradimed Co (IRMD) is a medical devices company listed on US.
Kellanova (K) is a packaged foods company listed on US.
Latest reported IRMD revenue for 2024-12-31 was $73.2M. Net income was $19.2M. Revenue was up 11.7% from 2023-12-31 to 2024-12-31. IRMD currently screens at market cap $1.19B and trailing P/E 50.9.
K does not have a complete income-statement cache yet.
IRMD currently screens at market cap $1.19B and trailing P/E 50.9. K currently screens at market cap $29.03B and trailing P/E 22.8.
Not investment advice. Open the IRMD and K stock pages for the full models.
Not investment advice.